174 related articles for article (PubMed ID: 3903249)
1. Clinical evaluation of the captopril screening test for primary aldosteronism.
Naomi S; Iwaoka T; Umeda T; Inoue J; Hamasaki S; Miura F; Fujii Y; Sato T
Jpn Heart J; 1985 Jul; 26(4):549-56. PubMed ID: 3903249
[TBL] [Abstract][Full Text] [Related]
2. The usefulness of the captopril test as a simultaneous screening for primary aldosteronism and renovascular hypertension.
Iwaoka T; Umeda T; Naomi S; Inoue J; Sasaki M; Yamauchi J; Sato T
Am J Hypertens; 1993 Nov; 6(11 Pt 1):899-906. PubMed ID: 8305162
[TBL] [Abstract][Full Text] [Related]
3. [The application of captopril challenge test in the diagnosis of primary aldosteronism].
Chen S; Zeng ZP; Song AL; Zhu L; Lu L; Tong AL; Shi C; Li HZ
Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):402-408. PubMed ID: 28592038
[No Abstract] [Full Text] [Related]
4. Diagnostic value of the post-captopril test in primary aldosteronism.
Castro OL; Yu X; Kem DC
Hypertension; 2002 Apr; 39(4):935-8. PubMed ID: 11967253
[TBL] [Abstract][Full Text] [Related]
5. The captopril challenge test for diagnosing primary Aldosteronism in a Chinese population.
Zhu KY; Zhang Y; Zhang WJ; Li HY; Feng WH; Zhu DL; Li P
BMC Endocr Disord; 2019 Jun; 19(1):65. PubMed ID: 31234846
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives.
Rossi E; Regolisti G; Negro A; Sani C; Davoli S; Perazzoli F
Am J Hypertens; 2002 Oct; 15(10 Pt 1):896-902. PubMed ID: 12372677
[TBL] [Abstract][Full Text] [Related]
7. Effects of sodium intake on the captopril test for primary aldosteronism.
Naomi S; Umeda T; Iwaoka T; Sato T
Jpn Heart J; 1987 May; 28(3):357-65. PubMed ID: 3306011
[TBL] [Abstract][Full Text] [Related]
8. [Detection of primary aldosteronism using the captopril test].
Pirich K; Vierhapper H; Graninger W; Nowotny P; Waldhäusl W
Wien Klin Wochenschr; 1987 Sep; 99(17):608-11. PubMed ID: 3314169
[TBL] [Abstract][Full Text] [Related]
9. Single dose captopril as a diagnostic test for primary aldosteronism.
Lyons DF; Kem DC; Brown RD; Hanson CS; Carollo ML
J Clin Endocrinol Metab; 1983 Nov; 57(5):892-6. PubMed ID: 6352726
[TBL] [Abstract][Full Text] [Related]
10. The impaired control of plasma renin activity in hypertensive patients with end-stage renal disease due to chronic glomerulonephritis.
Yasuda G; Nagasawa T; Umemura S; Shionoiri H; Ishii M
Clin Nephrol; 1994 Nov; 42(5):300-8. PubMed ID: 7851031
[TBL] [Abstract][Full Text] [Related]
11. [The Diagnostic Value of Captopril Challenge Test for Primary Aldosteronism].
Chen SH; Luo PY; Yu YR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Jan; 52(1):134-141. PubMed ID: 33474903
[TBL] [Abstract][Full Text] [Related]
12. Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit S; Bernheim J; Podjarny E
Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
[TBL] [Abstract][Full Text] [Related]
13. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
[TBL] [Abstract][Full Text] [Related]
14. Is single oral administration of captopril beneficial in screening for primary aldosteronism?
Muratani H; Abe I; Tomita Y; Ueno M; Kawazoe N; Kimura Y; Tsuchihashi T; Takishita S; Uezono K; Kawasaki T
Am Heart J; 1986 Aug; 112(2):361-7. PubMed ID: 3526854
[TBL] [Abstract][Full Text] [Related]
15. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA
Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579
[TBL] [Abstract][Full Text] [Related]
16. The Value of Different Single or Combined Indexes of the Captopril Challenge Test in the Diagnosis of Primary Aldosteronism.
Xiang Q; Chen T; Yu K; Li Y; Li Q; Tian H; Ren Y
Front Endocrinol (Lausanne); 2021; 12():689618. PubMed ID: 34220715
[TBL] [Abstract][Full Text] [Related]
17. [Usefulness of converting enzyme inhibitors in diagnosis of renovascular hypertension. I. Comparison of the effect of angiotensin converting enzyme inhibition on blood pressure and plasma renin activity in patients with primary hypertension and renovascular hypertension].
Posadzy-Małaczyńska A
Przegl Lek; 1997; 54(5):314-9. PubMed ID: 9380805
[TBL] [Abstract][Full Text] [Related]
18. Predictors of confirmatory test results for the diagnosis of primary hyperaldosteronism in hypertensive patients with an aldosterone-to-renin ratio greater than 20. The SHRIMP study.
Okamoto R; Taniguchi M; Onishi Y; Kumagai N; Uraki J; Fujimoto N; Fujii E; Yano Y; Ogura T; Ito M
Hypertens Res; 2019 Jan; 42(1):40-51. PubMed ID: 30401909
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication.
Seiler L; Rump LC; Schulte-Mönting J; Slawik M; Borm K; Pavenstädt H; Beuschlein F; Reincke M
Eur J Endocrinol; 2004 Mar; 150(3):329-37. PubMed ID: 15012618
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of primary aldosteronism: comparison of post-captopril active renin concentration and plasma renin activity.
Wu VC; Kuo CC; Chang HW; Tsai CT; Lin CY; Lin LY; Lin YH; Wang SM; Huang KH; Fang CC; Ho YL; Liu KL; Chang CC; Chueh SC; Lin SL; Yen RF; Wu KD;
Clin Chim Acta; 2010 May; 411(9-10):657-63. PubMed ID: 20117105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
